Robert W. Duggan - May 20, 2021 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Sandra Gardiner, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
May 20, 2021
Transactions value $
$0
Form type
4
Date filed
5/21/2021, 05:04 PM
Previous filing
May 14, 2021
Next filing
Jul 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Award $0 +20K $0.00 20K May 20, 2021 Common Stock 20K $18.69 Direct F1
transaction PLSE Stock Option (right to buy) Award $0 +11.6K $0.00 11.6K May 20, 2021 Common Stock 11.6K $18.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date.
F2 The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date.